Skip to main content
OpenTrials

Clinical trial condition

Biliary Tract Neoplasms

Explore clinical trials studying Biliary Tract Neoplasms. Study availability and eligibility vary by location and protocol.

327 public trials 104 recruiting studies
Refine in advanced search Browse all conditions

Biliary Tract Neoplasms trial results

Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

NCT00423254

Conditions
Adenocarcinoma, Adenoma, Anal Carcinoma, +97 more
Locations
  • Arizona Cancer Center Tuscon, Arizona, United States
  • Lombardi Comprehensive Cancer Center at Georgetown Washington D.C., District of Columbia, United States
  • H Lee Moffitt Cancer Center University of So Florida Tampa, Florida, United States
  • Nevada Cancer Institute Sparks, Nevada, United States
View Trial Details
Completed

Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer

NCT00380588

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan
View Trial Details
Active, Not Recruiting

A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer

NCT02711553

Conditions
Advanced Cancer, Biliary Tract Cancer, Biliary Tract Diseases, +10 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Florida School of Medicine Gainesville, Florida, United States
View all 82 locations
View Trial Details
Active, Not Recruiting

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

NCT06109779

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
View all 177 locations
View Trial Details
Active, Not Recruiting

The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer

NCT05036486

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations
  • Chang Gung Memorial Hospital, Chiayi Chiayi City, Taiwan
  • Kaohsiung Chang Gung Memorial Hospital Kaohsiung City, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View all 13 locations
View Trial Details
Active, Not Recruiting

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

NCT05775159

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
  • Research Site Kansas City, Kansas, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment

NCT05170438

Conditions
Advanced Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations
  • Chang Gung Memorial Hospital Kaohsiung City, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
  • National Cheng Kung University Hospital Tainan, Taiwan
View Trial Details

Related conditions